ThursdayOct 17, 2019 4:00 pm

Australian State Expands CBD Program for Epileptic Kids

As the regulations on CBD get less strict, more people have been exposed to the compound, and the numerous medical benefits it has to offer. While scientific research is still scarce, there's plenty of anecdotal evidence on the effectiveness of cannabidiol, and more people are taking notice of it and of the numerous ailments it is effective against. In Australia, Victoria has been at the forefront of the medical cannabis campaign. It started in December 2015 with the announcing of the Access to Medical Cannabis Bill. 2017 brought about the Andrews Labor Government's Compassionate Access Scheme, which gave 29 children…

Continue Reading

ThursdayOct 17, 2019 1:22 pm

Neutra Corp. (NTRR) to Release Hemp-Based VIVIS Skin Cream

Neutra Corp. subsidiary VIVIS recently announced the formal release of its hemp-based transdermal skin cream Neutra Corp. is an early-stage research and development company that is interested in developing products for healthy living, particularly relating to air quality and the use of CBD products derived from hemp The company is interested in the development and retail of hemp-based cannabidiol products such as skin creams, which can be used by athletes and sports enthusiasts Neutra Corp. acquired VIVIS in September 2019 to increase the company’s presence in the growing CBD market sector Neutra Corp. (OTCQB: NTRR) is an early stage research…

Continue Reading

ThursdayOct 17, 2019 9:00 am

Trial to Investigate the Use of Cannabidiol to Treat Psychosis Induced by Parkinson’s

CBD has built quite a reputation in the few years it has been mainstream. The list of diseases CBD has in the past proven effective against spans from minor conditions such as anxiety and inflammation to severe ones like chronic pain and epilepsy. At this point, it's anyone's guess what else cannabidiol works against. A new clinical trial will investigate the efficacy of CBD on patients who have Parkinson's induced psychosis. Parkinson's UK, in partnership with scientists at King's College London, will lead the study, and it has invested €1.2 million ($1.3 million) in a Phase 2 clinical trial. Parkinson's…

Continue Reading

WednesdayOct 16, 2019 4:00 pm

Food Supplement Industry Pushes Congress on CBD Product Sales

CBD products have become immensely popular in the preceding decade, owing to the host of medical benefits that users get. For a long time, people shied away from cannabidiol due to its connection to THC, but that's slowly changed over the years. Last year the Farm Bill was passed, and it legalized the industrial cultivation of hemp from where CBD is extracted. However, the industry has been plagued by a lack of regulations, and Congress is under even more pressure to speed up their efforts in crafting suitable legislation for the industry. Four trade associations representing the dietary supplement industry…

Continue Reading

WednesdayOct 16, 2019 9:00 am

University of Pennsylvania to Study CBD Use in Dogs

Every decade or two, there are medical discoveries made that thoroughly shake up the entire pharmaceutical industry. Drugs such as penicillin, insulin, and thorazin not only changed the scope of how severe medical conditions could be treated, but they were instrumental in helping thousands, if not millions of people, live more comfortable and healthy lives. CBD is, without a doubt, this decade's superstar. More and more people have started to take notice as testimonials and tons of anecdotal evidence about cannabidiol's effectiveness pile up. CBD works against pain, inflammation, anxiety, and a host of other conditions quite well. So well,…

Continue Reading

TuesdayOct 15, 2019 4:00 pm

Luxembourg to Impose a 50% Tax on CBD

Very few products could lay claim to the versatility that CBD offers consumers. Derived from the hemp plant, this non-psychoactive cannabinoid has been making waves recently, primarily because it is packed with a plethora of medical benefits. CBD can be used to address insomnia, chronic pain from arthritis, anxiety and a host of other conditions. Naturally, a product with this many benefits is bound to have a lot of demand, and high demand usually results in higher prices and higher profit margins.  This has attracted a ton of sellers, each looking to make a buck or two from the new…

Continue Reading

TuesdayOct 15, 2019 12:04 pm

Geyser Brands Inc. (TSX.V: GYSR) Launches a New, All-Natural Luxury Product Line

The new high-end product line solidifies Geyser’s position as an early mover in the hemp-based health and wellness market STōND features an array of natural skin care and wellness products that are 100-percent natural and formulated with cannabis sativa hemp oil The product line consists of body lotions, massage oils, mud masks, headache roll-ons, joint creams, anti-wrinkle serums and others A newly launched luxury hemp-based product line positions Geyser Brands Inc. (TSX.V: GYSR) as a leader in the cannabis wellness market. STōND is a line of 100-percent natural self-care products formulated with cannabis sativa hemp oil and features a wide…

Continue Reading

TuesdayOct 15, 2019 9:00 am

Iowa Parents Struggle to Find Doctors to Recommend Cannabidiol

Cannabidiol (CBD) has quickly surfaced as one of the most versatile and effective medical treatments around. From simple ailments such as pain and inflammation to severe conditions such as diabetes and epilepsy, CBD has proven to be effective at managing a variety of disorders. Despite the plethora of anecdotal evidence on the efficacy of CBD, there has been limited scientific research on the matter, and due to this, medical professionals have been slow to recommend the product to their patients. Amber Nelson, a mother from Cedar Rapids, Iowa, has been struggling to find help for her autistic son. She says…

Continue Reading

MondayOct 14, 2019 4:00 pm

UC San Diego to Fund CBD Benefits Research

Cannabidiol is one of the most controversial medical treatments of the decade. While plenty of people swear that they experienced varied health benefits after using CBD, some are more cynical, citing a lack of scientific research on the efficacy and side effects of the cannabinoid. Indeed, the limited amount of scientific research and evidence has been a thorn in CBD's side, and it's one of the main reasons a lot of people shy away from the product. However, there may be a reprieve for those who turn to CBD for their medical needs. The Center for Medical Cannabis Research (CMCR)…

Continue Reading

MondayOct 14, 2019 11:35 am

ChineseInvestors.com Inc. (CIIX) Penetrates Asian Markets via Popular Shopping Platform

CIIX subsidiary CBD Biotech Inc. has expanded into seven powerful Asian markets The Southeast Asia e-commerce market is projected to reach $230 billion by 2025 Via Shopee, the company has access to over seven million active buyers across multiple countries ChineseInvestors.com Inc. (OTCQB: CIIX), a provider of financial information and services to a global Chinese speaking community, announced that its wholly owned subsidiary, CBD Biotech Inc., has expanded into six new countries and a new region of China (http://cnw.fm/Q11bw) – seven significant markets. While CIIX is still focused on its original mission of providing financial information in the Chinese language character sets,…

Continue Reading

CBDWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000